Allergan in $600 million Botox settlement 02-Sep-2010 Allergan has agreed to pay $375 million to settle criminal charges and $225 million to resolve civil claims as part of a settlement with the US Department of Justice over the company’s US sales and marketing practices related to Botox (onabotulinumtoxinA), which the government maintains the firm was promoting for a number of unapproved uses. Read more... US News in Brief, September 2, 2010 02-Sep-2010 Lilly Evista patents upheld GSK epilepsy drug delayed Pompe drug wins orphan status Genentech cancer drug delayed S-A offers $18.5 bln for Genzyme Read more... Novartis wins FDA nod for blood pressure pill 27-Aug-2010 Novartis has won US Food and Drug Administration approval for a high blood pressure therapy called Tekamlo, which is a single-pill combination of the company’s renin inhibitor Tekturna (aliskiren) and the calcium channel blocker amlodipine, which is the active ingredient in Pfizer’s top-selling high blood pressure medication Norvasc Read more... J&J’s DePuy recalls devices 27-Aug-2010 Johnson & Johnson’s DePuy Orthopaedics unit is recalling two kinds of hip implants that appear to be linked to the need for a higher number of second procedures known as revision surgeries Read more... AARP reports drugs price increase 2009 26-Aug-2010 Retail prices for popular brand name drugs “skyrocketed” by more than eight percent last year in spite of a negative general inflation rate, according to AARP Read more... Leader of the pack 26-Aug-2010 Being a leader can be tough work in challenging times Read more... US News in Brief, August 26, 2010 26-Aug-2010 Cephalon CEO on leave Stem cell ruling will be appealed P&G to co-promote sleep drug EpiCept Ceplene NDA rejected Pfizer lung cancer study disappoints FDA advisors back expanded Cymbalta use Jazz drug nixed by FDA advisors Read more... Bill would increase FDA recall powers 06-Aug-2010 New legislation has been introduced in the Senate that would give the US Food and Drug Administration the authority to force companies to recall drugs in cases in which the products have been found to be contaminated or unsafe Read more... US News in Brief, August 6, 2010 06-Aug-2010 Study suggests bias in industry research FDA lifts hold on stem-cell trial New flu shots approved GSK forms two new drug partnerships New recommendations on FDA device reviews  Read more... US News in Brief, July 30, 2010 30-Jul-2010 FDA clears Daiichi hypertension drug Merck Serono MS pill wins priority review Astellas and Regeneron extend deal Counterfeit medicines summit FDA approves drug for drooling Read more...

Page  1 2 3